• In August 2026, Xometry, Inc. reported second-quarter sales of US$229.28 million, sharply reduced its net loss to US$5.31 million, and raised its full-year 2026 revenue growth outlook to 33%–34%, supported by strong marketplace expansion and new third-quarter guidance of US$234 million to US$236 million.
• The combination of faster marketplace growth and narrowing losses signals that Xometry’s AI-powered manufacturing platform is scaling operationally while still investing heavily for expansion.
• We’ll now examine how the upgraded full-year revenue guidance reshapes Xometry’s existing investment narrative and the risks analysts highlight.

AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Xometry Investment Narrative Recap

To own Xometry, you need to believe its AI marketplace can keep adding high-value buyers and suppliers while steadily closing the gap to consistent profitability. The latest quarter’s stronger revenue and sharply reduced net loss support that thesis and slightly ease the biggest near term worry around ongoing losses. At the same time, guidance still highlights a key short term catalyst in marketplace growth, while the risk of prolonged unprofitability and potential dilution has not gone away.

The most relevant recent announcement is Xometry’s upgraded full year 2026 revenue growth outlook to 33% to 34%, underpinned by an expected 37% marketplace growth rate. This pairs with new third quarter guidance of US$234 million to US$236 million in revenue, framing how quickly the core marketplace is scaling relative to costs. Together, these updates help you weigh whether the current pace of adoption is sufficient to justify continued heavy investment in technology and international expansion.

Yet despite this progress, investors still need to be aware of the risk that sustained high operating expenses could...

Xometry’s narrative projects $1.5 billion revenue and $127.5 million earnings by 2029. This requires 22.2% yearly revenue growth and a $158.3 million earnings increase from -$30.8 million today.

Uncover how Xometry's forecasts yield a $109.12 fair value, a 13% upside to its current price.

Exploring Other Perspectives

While consensus focuses on steady scaling, the most optimistic analysts once projected US$1.4 billion revenue and US$102.5 million earnings by 2029, assuming Xometry overcomes risks like large OEMs bypassing third party platforms altogether.

Explore 5 other fair value estimates on Xometry - why the stock might be worth less than half the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Xometry research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Xometry research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xometry's overall financial health at a glance.

Seeking Other Investments?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.